Tudor Investment Corp ET AL Cuts Stake in The Chemours Company (NYSE:CC)

Tudor Investment Corp ET AL trimmed its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 502,824 shares of the specialty chemicals company's stock after selling 22,334 shares during the quarter. Tudor Investment Corp ET AL owned 0.34% of Chemours worth $8,498,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 765 shares during the period. Quadrant Capital Group LLC lifted its position in Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 1,119 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in Chemours in the fourth quarter valued at $48,000. KBC Group NV grew its position in Chemours by 38.2% during the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock worth $104,000 after purchasing an additional 1,708 shares during the period. Finally, Sterling Capital Management LLC raised its stake in shares of Chemours by 54.8% during the 4th quarter. Sterling Capital Management LLC now owns 8,453 shares of the specialty chemicals company's stock valued at $143,000 after buying an additional 2,991 shares during the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Mizuho set a $15.00 target price on Chemours in a report on Tuesday, April 15th. Barclays decreased their target price on shares of Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 1st. Truist Financial dropped their price target on shares of Chemours from $27.00 to $22.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. BMO Capital Markets dropped their price objective on Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group decreased their target price on Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a research report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Chemours presently has a consensus rating of "Moderate Buy" and an average price target of $21.56.

Chemours Trading Up 2.2 %

Shares of NYSE CC traded up $0.27 during trading on Friday, hitting $12.47. 1,885,956 shares of the company were exchanged, compared to its average volume of 1,878,312. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The Chemours Company has a 12-month low of $9.33 and a 12-month high of $29.21. The company has a fifty day moving average price of $12.87 and a 200-day moving average price of $16.81. The firm has a market capitalization of $1.86 billion, a PE ratio of 21.88 and a beta of 1.76.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.37 billion. As a group, equities research analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.02%. The ex-dividend date was Friday, February 28th. Chemours's dividend payout ratio is presently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.